申请人:ELI LILLY AND COMPANY
公开号:EP0182533A2
公开(公告)日:1986-05-28
The invention relates to imidazolium salts which are effective in lowering blood glucose levels in mammals. In particular, there is provided a compound of formula (I) which is useful in lowering blood glucose levels:
in which:
R1 is C1-C4 alkyl;
R2 and R3, independently, are hydrogen or C1-C4 alkyl;
each R4, independently is, -OR5, -NR6R7, C1-C4 alkyl, C1-C4 alkoxy, trifluoromethyl, or C1-C4 alkylthio;
R5 is hydrogen or
R6 is hydrogen, C1-C4 alkyl, or -C-R8;
R7 is hydrogen or C1-C4 alkyl;
each R8, independently, is C1-C4 alkyl or phenyl;
Z is oxygen or sulfur;
X is a therapeutically acceptable anion; and m is 0, 1 or 2.
本发明涉及可有效降低哺乳动物血糖水平的咪唑盐。 特别是提供了一种有助于降低血糖水平的式 (I) 化合物:其中: R1为C1-C4烷基;R2和R3独立地为氢或C1-C4烷基;每个R4独立地为-OR5、-NR6R7、C1-C4烷基、C1-C4烷氧基、三氟甲基或C1-C4烷硫基;R5为氢或R6为氢、C1-C4烷基或-C-R8;R7为氢或C1-C4烷基;每个R8独立地为C1-C4烷基或苯基;Z为氧或硫;X为治疗上可接受的阴离子;m为0、1或2。